Study guide
8.2 Pharmaceutical Calculations and Clinical Math
PEBC Pharmacist Evaluating Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & The Canadian Pharmacy Practice Landscape
1.1 PEBC EE Blueprint, Format, Scoring, and IPG Certification Pathway 1.2 The Canadian Healthcare System, Canada Health Act, and Drug Regulation 1.3 Canadian Pharmacy Regulatory Framework, NAPRA Standards, and Professional Legislation
2 Chapter 2: Pharmaceutics & Drug Delivery Systems
2.1 Physicochemical Principles, Solubility, Ionization, and Stability 2.2 Solid Dosage Forms, Formulation Science, and Modified-Release Technologies 2.3 Liquid and Semisolid Dosage Forms, Dispersions, and Topical Delivery 2.4 Sterile Product Principles, Parenteral Delivery, and Biopharmaceuticals 2.5 Pharmaceutical Quality: GMP, Stability Testing, and Bioequivalence
3 Chapter 3: Biopharmaceutics & Clinical Pharmacokinetics
3.1 Drug Absorption, Distribution, Metabolism, and Elimination (ADME) 3.2 Bioavailability, Bioequivalence, and Biopharmaceutics Classification System (BCS) 3.3 Pharmacokinetic Modeling, Parameters, and Dosing Calculations 3.4 Therapeutic Drug Monitoring (TDM) and Clinical Application
4 Chapter 4: Pharmacology, Toxicology & Pharmacogenetics
4.1 Autonomic and Central Nervous System Pharmacology 4.2 Cardiovascular, Renal, and Endocrine Pharmacology 4.3 Clinical Toxicology, Overdose Management, and Antidotes 4.4 Biologics, Biosimilars, and Pharmacogenetics
5 Chapter 5: Pathophysiology & Clinical Assessment
5.1 Clinical Laboratory Diagnostics, Biomarkers, and Vital Signs 5.2 Cardiovascular and Respiratory Pathophysiology 5.3 Endocrine, Renal, and Gastrointestinal Pathophysiology 5.4 Neurologic, Psychiatric, and Musculoskeletal Pathophysiology 5.5 Physical Assessment and Point-of-Care Testing
6 Chapter 6: Pharmacotherapy & Minor Ailments
6.1 Cardiovascular Pharmacotherapy & Evidence-Based Guidelines 6.2 Endocrine and Metabolic Pharmacotherapy 6.3 Infectious Diseases and Antimicrobial Stewardship 6.4 Neurologic, Psychiatric, and Pain Management Therapeutics 6.5 Minor Ailment Prescribing and Nonprescription Therapy 6.6 Respiratory Pharmacotherapy: Asthma, COPD, and Inhaled Therapy 6.7 Gastrointestinal and Hepatic Pharmacotherapy 6.8 Renal, Fluid, and Electrolyte Therapeutics 6.9 Musculoskeletal and Rheumatologic Pharmacotherapy 6.10 Dermatologic, Ophthalmic, and Ear-Nose-Throat Pharmacotherapy 6.11 Hematologic, Immunologic, and Oncology Supportive Care 6.12 Women's Health, Men's Health, and Urologic Therapeutics 6.13 Nutrition, Natural Health Products, and Complementary Medicine
7 Chapter 7: Special Populations & Applied Therapeutics
7.1 Geriatric Pharmacotherapy and Deprescribing 7.2 Pediatric and Neonatal Pharmacotherapy 7.3 Perinatal Pharmacotherapy: Pregnancy and Lactation 7.4 Dosage Adjustments in Renal and Hepatic Impairment
8 Chapter 8: Prescription Processing, Calculations & Compounding
8.1 Prescription Processing, Verification, and Drug Therapy Problem Management 8.2 Pharmaceutical Calculations and Clinical Math 8.3 Non-Sterile Compounding and NAPRA Standards 8.4 Sterile and Hazardous Compounding under NAPRA Standards 8.5 Advanced Calculations: Infusion Rates, Parenteral Nutrition, and Renal Estimation
9 Chapter 9: Health Equity, Indigenous Health & Pharmacy Bioethics
9.1 Social Determinants of Health and Health Equity 9.2 Indigenous Health, Cultural Safety, and Humility 9.3 Pharmacy Bioethics, Informed Consent, and Professional Boundaries 9.4 Health Promotion, Disease Prevention, and Public Health
10 Chapter 10: Evidence Appraisal, Safety & Practice Management
10.1 Biostatistics and Critical Appraisal of Clinical Literature 10.2 Pharmacoeconomics and Pharmacoepidemiology 10.3 Medication Safety, Incident Analysis, and Quality Improvement 10.4 Pharmacy Operations, Cold-Chain Management, and Emergency Preparedness 10.5 Drug Information and Evidence-Based Decision Making 10.6 Pharmacovigilance and Adverse Drug Reaction Reporting in Canada
11 Chapter 11: Patient Care Process, Communication & Collaborative Practice
11.1 The Patient Care Process: Assessment, Care Plans, and Follow-Up 11.2 Patient and Caregiver Communication, Education, and Health Literacy 11.3 Motivational Interviewing and Shared Decision-Making 11.4 Intra- and Interprofessional Collaborative Care
12 Chapter 12: Medication Administration, Devices & Expanded Scope
12.1 Injection and Vaccine Administration Technique 12.2 Immunization Schedules, Vaccine Selection, and Travel Health 12.3 Home Medical Devices and Device Technique Coaching 12.4 Expanded Scope: Adapting, Renewing, Initiating, and Medication Reconciliation
13 Chapter 13: Pharmacy Management, Finance & Practice Leadership
13.1 Human Resources, Leadership, and Change Management 13.2 Financial Management, Drug Plans, and Marketing 13.3 Quality Improvement, Risk Management, and Workplace Safety
8.2 Pharmaceutical Calculations and Clinical Math
Key Takeaways Explain This Topic AI
Alligation alternate is a fundamental matrix method used to calculate the relative parts of two or more preparations of known strengths needed to formulate a mixture of a desired intermediate concentration.
Renal estimation on this exam follows the PEBC reference sheet supplied in the exam: creatinine clearance for males is (140 minus age) times actual body weight in kilograms times 1.2, divided by serum creatinine in micromoles per litre, and the female value is 0.85 times the male result.
Sodium chloride equivalent (E-value) calculations ensure isotonicity of ophthalmic and parenteral solutions by determining the mass of sodium chloride represented by a given drug mass: E = 58.5 × i MW × 1.8 E = 58.5 \times \frac{i}{\text{MW} \times 1.8} E = 58.5 × MW × 1.8 i .
Electrolyte concentrations expressed in milliequivalents (mEq) depend directly on the formula weight and ionic valence of the chemical species: mEq = mg × valence MW \text{mEq} = \frac{\text{mg} \times \text{valence}}{\text{MW}} mEq = MW mg × valence , requiring caution when distinguishing monovalent from divalent ions.
Pediatric and chemotherapy dosing calculations require accurate calculation of Body Surface Area (BSA) using the Mosteller formula: BSA (m 2 ) = Height (cm) × Weight (kg) 3600 \text{BSA (m}^2\text{)} = \sqrt{\frac{\text{Height (cm)} \times \text{Weight (kg)}}{3600}} BSA (m 2 ) = 3600 Height (cm) × Weight (kg) .
Last updated: August 2026
8.2 Pharmaceutical Calculations and Clinical Math
Exam Focus: Pharmaceutical calculations are high-stakes, precision-critical items on the PEBC Evaluating Examination. Candidates must demonstrate flawless execution in unit conversions, alligation, renal function assessment (SI units), body surface area, electrolyte milliequivalents, isotonicity equivalents, and intravenous flow rates.
Use the constants PEBC gives you. The Evaluating Examination supplies a reference sheet of formulas on screen. Its Cockcroft-Gault entry reads: creatinine clearance for a male equals (140 minus age) times actual body weight in kilograms times 1.2 , divided by serum creatinine in micromol/L ; for a female , multiply the male result by 0.85 . Other textbooks print 1.23 and 1.04, or the milligram-per-decilitre form with a constant of 72 — those are valid variants, but on this exam answer with the sheet you are given. Clinically, ideal body weight is commonly substituted in underweight patients and adjusted body weight in obesity so that clearance is not overestimated.
Concentration Expressions and Dilution Principles
Pharmaceutical preparations express concentration in various standardized formats:
Percentage Concentrations:
Percent Weight-in-Volume (% w/v): Grams of solute per 100 mL of solution ( g / 100 mL \text{g}/100\text{ mL} g /100 mL ).
Percent Volume-in-Volume (% v/v): Milliliters of solute per 100 mL of solution ( mL / 100 mL \text{mL}/100\text{ mL} mL /100 mL ).
Percent Weight-in-Weight (% w/w): Grams of solute per 100 g of mixture ( g / 100 g \text{g}/100\text{ g} g /100 g ).
Ratio Strength: Expressed as 1 : X 1 : X 1 : X , indicating 1 g 1\text{ g} 1 g of solute in X mL X\text{ mL} X mL (for solutions) or 1 g 1\text{ g} 1 g of solute in X g X\text{ g} X g (for solids). To convert a ratio strength to percentage: % = 100 X \% = \frac{100}{X} % = X 100 .
Parts Per Million (PPM): Represents 1 part 1\text{ part} 1 part solute per 1 , 000 , 000 parts 1,000,000\text{ parts} 1 , 000 , 000 parts total volume or mass (equivalent to 1 mg / L 1\text{ mg}/\text{L} 1 mg / L or 1 mcg / mL 1\text{ mcg}/\text{mL} 1 mcg / mL in aqueous systems).
Dilution and Concentration Formula
For single-source dilutions and concentrations without chemical interaction: C 1 × V 1 = C 2 × V 2 C_1 \times V_1 = C_2 \times V_2 C 1 × V 1 = C 2 × V 2
where C C C is concentration and V V V is volume (or mass M M M ).
Alligation Alternate and Alligation Medial
Alligation Alternate is used when mixing two or more components of different known concentrations to prepare a desired intermediate concentration. +-------------------------------------------------------------------------+
- | ALLIGATION ALTERNATE GRID |
- +-------------------------------------------------------------------------+
- | |
- | Higher Strength (H) \ / (D - L) = Parts of Higher |
- | \ / |
- | Desired (D) |
- | / \ |
- | Lower Strength (L) / \ (H - D) = Parts of Lower |
- | |
- | Total Parts = (D - L) + (H - D) |
- +-------------------------------------------------------------------------+
- Step-by-Step Calculation Protocol
Place the higher concentration ( H H H ) in the upper left and lower concentration ( L L L ) in the lower left.
Place the desired concentration ( D D D ) in the center.
Subtract diagonally: ( D − L ) (D - L) ( D − L ) yields parts of the higher component; ( H − D ) (H - D) ( H − D ) yields parts of the lower component.
Sum the parts to obtain total parts.
Calculate the volume or mass required for each component: Volume needed = Total desired volume × Component parts Total parts \text{Volume needed} = \text{Total desired volume} \times \frac{\text{Component parts}}{\text{Total parts}} Volume needed = Total desired volume × Total parts Component parts .
Note on Diluents: Pure water or an unmedicated base has a concentration of 0 % 0\% 0% . Pure active pharmaceutical ingredient (API) powder has a concentration of 100 % 100\% 100% .
Renal Function Assessment: Cockcroft-Gault in SI Units
In Canadian clinical practice, clinical chemistry laboratories report serum creatinine ( S C r SCr SC r ) in micromoles per liter ( μ mol/L \mu\text{mol/L} μ mol/L ) rather than mg/dL. Pharmacists must utilize the SI version of the Cockcroft-Gault equation for medication dosage adjustment.
Cockcroft-Gault Formula (SI Units) CrCl (mL/min) = ( 140 − Age ) × Weight (kg) × 1.2 S C r ( μ mol/L ) [ For Males ] \text{CrCl (mL/min)} = \frac{(140 - \text{Age}) \times \text{Weight (kg)} \times 1.2}{SCr\ (\mu\text{mol/L})} \quad [\text{For Males}] CrCl (mL/min) = SC r ( μ mol/L ) ( 140 − Age ) × Weight (kg) × 1.2 [ For Males ] CrCl (mL/min) = 0.85 × ( 140 − Age ) × Weight (kg) × 1.2 S C r ( μ mol/L ) [ For Females ] \text{CrCl (mL/min)} = 0.85 \times \frac{(140 - \text{Age}) \times \text{Weight (kg)} \times 1.2}{SCr\ (\mu\text{mol/L})} \quad [\text{For Females}] CrCl (mL/min) = 0.85 × SC r ( μ mol/L ) ( 140 − Age ) × Weight (kg) × 1.2 [ For Females ]
(Note: these are the constants printed on the PEBC reference sheet supplied during the examination. Some textbooks use 1.23 1.23 1.23 for males and 1.04 1.04 1.04 for females instead; the results differ by under 3% and almost never cross a dosing threshold.)
Body Weight Selection for Cockcroft-Gault
Ideal Body Weight (IBW) - Devine Formula: IBW (Males) = 50 kg + 2.3 kg × ( Height in inches − 60 ) \text{IBW (Males)} = 50\text{ kg} + 2.3\text{ kg} \times (\text{Height in inches} - 60) IBW (Males) = 50 kg + 2.3 kg × ( Height in inches − 60 ) IBW (Females) = 45.5 kg + 2.3 kg × ( Height in inches − 60 ) \text{IBW (Females)} = 45.5\text{ kg} + 2.3\text{ kg} \times (\text{Height in inches} - 60) IBW (Females) = 45.5 kg + 2.3 kg × ( Height in inches − 60 ) (Conversion: 1 inch = 2.54 cm 1\text{ inch} = 2.54\text{ cm} 1 inch = 2.54 cm )
Adjusted Body Weight (AdjBW / ABW): AdjBW = IBW + 0.4 × ( Actual Weight − IBW ) \text{AdjBW} = \text{IBW} + 0.4 \times (\text{Actual Weight} - \text{IBW}) AdjBW = IBW + 0.4 × ( Actual Weight − IBW )
Weight Selection Rules:
Actual Weight < IBW: Use Actual Weight (underweight patients; using IBW would overestimate renal function).
Actual Weight within 100% - 120% of IBW: Use IBW (or Actual Weight per specific institutional protocols).
Actual Weight > 120% of IBW (Obese): Use Adjusted Body Weight (AdjBW) for most hydrophilic renally eliminated drugs (e.g., aminoglycosides, vancomycin, DOACs).
- Patient Weight Status Criterion Recommended Weight in CrCl Calculation
- Underweight Actual Weight < IBW \text{Actual Weight} < \text{IBW} Actual Weight < IBW Actual Body Weight
Normal Weight Actual Weight = 100 % to 120 % of IBW \text{Actual Weight} = 100\%\text{ to }120\%\text{ of IBW} Actual Weight = 100% to 120% of IBW Ideal Body Weight (IBW)
Obese Actual Weight > 120 % of IBW \text{Actual Weight} > 120\%\text{ of IBW} Actual Weight > 120% of IBW Adjusted Body Weight (AdjBW)
Isotonicity and Sodium Chloride Equivalent ( E E E -Value)
Ophthalmic, nasal, and parenteral solutions must be formulated to match the osmotic pressure of physiological body fluids ( 0.9 % w/v NaCl 0.9\%\text{ w/v NaCl} 0.9% w/v NaCl , corresponding to an osmolarity of ∼ 290 − 300 mOsm/L \sim 290-300\text{ mOsm/L} ∼ 290 − 300 mOsm/L ). The Sodium Chloride Equivalent ( E E E -value) represents the weight of sodium chloride that produces the same osmotic effect as 1 g 1\text{ g} 1 g of the drug substance.
Mathematical Formulation E = 58.5 × i MW × 1.8 E = 58.5 \times \frac{i}{\text{MW} \times 1.8} E = 58.5 × MW × 1.8 i
where 58.5 58.5 58.5 is the molecular weight of NaCl \text{NaCl} NaCl , 1.8 1.8 1.8 is the dissociation factor ( i i i ) of NaCl \text{NaCl} NaCl , MW \text{MW} MW is the molecular weight of the drug, and i i i is the dissociation factor of the drug.
- Dissociation Factor ( i i i ) Values based on Ionic Dissociation
- Non-electrolytes (e.g., dextrose, glycerin, urea): i = 1.0 i = 1.0 i = 1.0
Substances dissociating into 2 ions (e.g., NaCl \text{NaCl} NaCl , KCl \text{KCl} KCl , ephedrine HCl \text{ephedrine HCl} ephedrine HCl ): i = 1.8 i = 1.8 i = 1.8
Substances dissociating into 3 ions (e.g., CaCl 2 \text{CaCl}_2 CaCl 2 , sodium citrate \text{sodium citrate} sodium citrate ): i = 2.6 i = 2.6 i = 2.6
Substances dissociating into 4 ions (e.g., ferric chloride \text{ferric chloride} ferric chloride ): i = 3.4 i = 3.4 i = 3.4
- Substances dissociating into 5 ions: i = 4.2 i = 4.2 i = 4.2
- Calculating Mass of NaCl \text{NaCl} NaCl Required for Isotonicity
Calculate total mass of NaCl \text{NaCl} NaCl required for an unmedicated isotonic solution: Total NaCl (g) = 0.009 × Target Volume (mL) \text{Total NaCl (g)} = 0.009 \times \text{Target Volume (mL)} Total NaCl (g) = 0.009 × Target Volume (mL) .
Calculate NaCl \text{NaCl} NaCl tonicity contribution of each drug: Drug NaCl contribution (g) = Mass of drug (g) × E \text{Drug NaCl contribution (g)} = \text{Mass of drug (g)} \times E Drug NaCl contribution (g) = Mass of drug (g) × E .
Subtract drug contributions from total NaCl \text{NaCl} NaCl : NaCl to add (g) = Total NaCl − ∑ ( Mass of drug × E ) \text{NaCl to add (g)} = \text{Total NaCl} - \sum(\text{Mass of drug} \times E) NaCl to add (g) = Total NaCl − ∑ ( Mass of drug × E ) .
If an isotonic agent other than NaCl \text{NaCl} NaCl is used (e.g., boric acid, dextrose), divide the calculated NaCl \text{NaCl} NaCl mass by that agent's E E E -value: Mass of agent = NaCl to add (g) E agent \text{Mass of agent} = \frac{\text{NaCl to add (g)}}{E_{\text{agent}}} Mass of agent = E agent NaCl to add (g) .
Electrolyte Calculations: Milliequivalents and Millimoles
Electrolytes in clinical solutions (e.g., IV maintenance fluids, parenteral nutrition) are quantified in millimoles (mmol) and milliequivalents (mEq). +-------------------------------------------------------------------------+
- | ELECTROLYTE RELATIONSHIP FORMULAS |
- +-------------------------------------------------------------------------+
- | |
- | \text{moles} = \frac{\text{grams}}{\text{MW}} |
- | |
- | \text{millimoles (mmol)} = \frac{\text{milligrams (mg)}}{\text{MW}} |
- | |
- | \text{milliequivalents (mEq)} = \text{mmol} \times \text{valence} |
- | |
- | \text{mEq} = \frac{\text{mg} \times \text{valence}}{\text{MW}} |
- | |
- +-------------------------------------------------------------------------+
- Electrolyte Species Chemical Formula Valence ( z z z ) Molecular / Formula Weight (g/mol)
- Sodium Chloride NaCl \text{NaCl} NaCl 1 58.5
- Potassium Chloride KCl \text{KCl} KCl 1 74.5
- Calcium Chloride Dihydrate CaCl 2 ⋅ 2 H 2 O \text{CaCl}_2 \cdot 2\text{H}_2\text{O} CaCl 2 ⋅ 2 H 2 O 2 147
Calcium Gluconate Monohydrate C 12 H 22 CaO 14 ⋅ H 2 O \text{C}_{12}\text{H}_{22}\text{CaO}_{14} \cdot \text{H}_2\text{O} C 12 H 22 CaO 14 ⋅ H 2 O 2 448
Magnesium Sulfate Heptahydrate MgSO 4 ⋅ 7 H 2 O \text{MgSO}_4 \cdot 7\text{H}_2\text{O} MgSO 4 ⋅ 7 H 2 O 2 246.5
Sodium Bicarbonate NaHCO 3 \text{NaHCO}_3 NaHCO 3 1 84
Critical Note on Calcium Salts: 1 g 1\text{ g} 1 g of Calcium Chloride provides ∼ 13.6 mEq \sim 13.6\text{ mEq} ∼ 13.6 mEq of Ca 2 + \text{Ca}^{2+} Ca 2 + , whereas 1 g 1\text{ g} 1 g of Calcium Gluconate provides only ∼ 4.65 mEq \sim 4.65\text{ mEq} ∼ 4.65 mEq of Ca 2 + \text{Ca}^{2+} Ca 2 + . These salts are never interchangeable on a gram-for-gram basis.
Body Surface Area and Pediatric/Chemotherapy Dosing
Body Surface Area (BSA) normalizes dosing based on metabolic mass and cardiac output, standard for oncology chemotherapeutic agents and specialized pediatric regimens.
Mosteller Formula for BSA BSA ( m 2 ) = Height (cm) × Weight (kg) 3600 \text{BSA } (\text{m}^2) = \sqrt{\frac{\text{Height (cm)} \times \text{Weight (kg)}}{3600}} BSA ( m 2 ) = 3600 Height (cm) × Weight (kg)
Intravenous Flow Rates and Infusions Flow Rate (mL/hr) = Total Infusion Volume (mL) Infusion Time (hours) \text{Flow Rate (mL/hr)} = \frac{\text{Total Infusion Volume (mL)}}{\text{Infusion Time (hours)}} Flow Rate (mL/hr) = Infusion Time (hours) Total Infusion Volume (mL) Drip Rate (drops/min or gtt/min) = Total Volume (mL) × Drop Factor (gtt/mL) Time (minutes) \text{Drip Rate (drops/min or gtt/min)} = \frac{\text{Total Volume (mL)} \times \text{Drop Factor (gtt/mL)}}{\text{Time (minutes)}} Drip Rate (drops/min or gtt/min) = Time (minutes) Total Volume (mL) × Drop Factor (gtt/mL)